TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2009

A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium.

Natasha B Leighl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.